CD83 and neoplasm: In addition, Cindy et al. reported that the downregulation of CD83 expression on human DCs results in a weaker induction of allogeneic T−cell proliferation, reduced IFN−γ secretion from established T cells, and decreased priming of functional tumor antigen−specific CD8+ T lymphocytes [43].